Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neurology

• Publication date

  2005-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000173031.56429.04PMID 16116136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate mofetil for myasthenia gravis

  2003cited by this paper
• Primary brain lymphomas after kidney transplantation: presentation and outcome

  2003cited by this paper
• Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell Lymphoma

  2001cited by this paper
• Posttransplant primary CNS lymphoma.

  2000cited by this paper
• Association of primary central nervous system lymphoma with long‐term azathioprine therapy for myasthenia gravis?

  2000cited by this paper
• Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.

  1997cited by this paper
• Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study.

  1996cited by this paper
• Primary Central Nervous System Lymphoma

  1993cited by this paper
• Incidence and treatment of neoplasia after transplantation.

  1993cited by this paper

• Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

  2025cites this paper
• Reversible lymphoproliferative disorder in systemic lupus erythematosus treated with mycophenolate mofetil: A case report and literature review

  2025cites this paper
• Primary cerebral lymphoma and autoimmune hepatitis: an unusual case associated with prolonged treatment with mycophenolate mofetil.

  2025cites this paper
• Traditional treatments and different geographical approaches.

  2025cites this paper
• Targeted Treatments for Myasthenia Gravis in Children and Adolescents

  2024cites this paper
• Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.

  2024cites this paper
• Ocular Myasthenia Gravis

  2023cites this paper
• Epstein‑Barr virus‑associated primary central nervous system lymphoma in an immunosuppressed patient with a comorbid autoimmune disorder: A case report

  2023cites this paper
• Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma

  2023cites this paper
• The use of mycophenolate mofetil in interstitial lung diseases associated with rheumatic diseases

  2023cites this paper
• Clinical, imaging and histopathological features of concurrent malignancies in a dog: Meningoencephalitis of unknown origin and a malignant parotid gland carcinoma

  2022cites this paper
• Ocular Myasthenia Gravis

  2022cites this paper
• Acute inflammatory demyelinating polyneuropathy following Ciguatera poisoning

  2022cites this paper
• Iatrogenic immunodeficiency‐associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis

  2022influential citation
• Mycophenolates

  2021cites this paper
• Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review

  2021cites this paper
• Mycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma in Which a Solitary Lung Nodule Remitted Spontaneously

  2020influential citation
• Miastenia e sindromi miasteniche

  2020cites this paper
• Primary Central Nervous System Lymphoma Presenting as Multifocal Brain Abscesses

  2020cites this paper
• Understanding the burden of refractory myasthenia gravis

  2019cites this paper
• Myasthenia gravis: State of the art and new therapeutic strategies

  2019cites this paper
• A Neurologist's Perspective on Understanding Myasthenia Gravis: Clinical Perspectives of Etiologic Factors, Diagnosis, and Preoperative Treatment.

  2019cites this paper
• Maintenance immunosuppression in myasthenia gravis, an update.

  2019cites this paper
• Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma

  2018cites this paper
• Treatment of Myasthenia Gravis.

  2018cites this paper
• Advances in autoimmune myasthenia gravis management

  2018cites this paper
• Myasthénies et syndromes myasthéniques

  2018cites this paper
• Myasthenia gravis

  2017cites this paper
• Myasthenia gravis: recent advances in immunopathology and therapy

  2017cites this paper
• Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

  2016influential citation
• Maintenance immunosuppression in myasthenia gravis.

  2016cites this paper
• Guidelines on dermatomyositis – excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology

  2016cites this paper
• Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease

  2016cites this paper
• Myasthenia gravis

  2016cites this paper
• Leitlinie Dermatomyositis – Auszug aus der interdisziplinären S2k‐Leitlinie zu Myositissyndromen der deutschen Gesellschaft für Neurologie

  2016cites this paper
• INTERNATIONAL CONSENSUS GUIDANCE FOR THE MANAGEMENT OF MYASTHENIA GRAVIS

  2016cites this paper
• Brainstem lymphoma in a myasthenia gravis patient on azathioprine.

  2015cites this paper
• Renal cell carcinoma with proliferative lupus nephritis

  2015cites this paper
• Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis

  2015cites this paper
• A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic

  2014cites this paper
• Treatment of MuSK-Associated Myasthenia Gravis

  2014cites this paper
• Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations

  2013cites this paper
• Lymphoproliferative disease of the central nervous system in a patient with dermatomyositis on immunomodulation therapy.

  2013cites this paper
• Diseases of the Neuromuscular Junction

  2012cites this paper
• Primary central nervous system lymphoma.

  2012cites this paper
• Myasthenia Gravis

  2012cites this paper
• 68 Diagnostik und Therapie der Myasthenia gravis und des Lambert-Eaton-Syndroms

  2012cites this paper
• Miastenie e sindromi miasteniche

  2011cites this paper
• Systemic Therapies in Pediatric Atopic Dermatitis

  2011cites this paper
• Myasthénies et syndromes myasthéniques

  2011cites this paper
• 7 – Principles and Guidelines of Immunotherapy in Neuromuscular Disorders

  2011cites this paper
• British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

  2011cites this paper
• Treatment of autoimmune hepatitis: A review of current and evolving therapies

  2011cites this paper
• Experience with Mycophenolate Mofetil among Jordanian Patients with Myasthenia Gravis

  2011cites this paper
• Treatment of Myasthenia Gravis

  2011cites this paper
• De novo appearance of primitive neuroectodermal tumor in a patient with systemic lupus erythematosus and moyamoya disease

  2010cites this paper
• [Treatment of autoimmune myasthenia].

  2010cites this paper
• Myasthenia gravis developing in a patient with CNS lymphoma

  2010cites this paper
• Traitement de la myasthénie auto-immune

  2010cites this paper
• Treatment of Neuromyelitis Optica With Mycophenolate Mofetil

  2009cites this paper
• T‐cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis

  2009cites this paper
• Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study

  2009cites this paper
• Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

  2009cites this paper
• Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

  2009cites this paper
• Mycophenolate mofetil in dermatology.

  2009cites this paper
• A 69‐YEAR‐OLD MAN WITH LEFT HEMISPHERIC NECROTIZING MASS LESION

  2009cites this paper
• Current treatments of chronic immune‐mediated demyelinating polyneuropathies

  2009cites this paper
• Medical treatment options for ocular myasthenia gravis

  2008cites this paper
• Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

  2008cites this paper
• POLYRADICULOPATHY DUE TO METHOTREXATE-INDUCED EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER

  2008cites this paper
• 3 – Therapy in Neuromuscular Diseases

  2008cites this paper
• Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications

  2008cites this paper
• Long-term safety of mycophenolate mofetil and cyclosporine: a review.

  2008cites this paper
• Idiopathic inflammatory myopathies: Current and future therapeutic options

  2008cites this paper
• Mycophenolate mofetil for myasthenia gravis: a clear and present controversy

  2008cites this paper
• Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.

  2007cites this paper
• Myasthenia gravis

  2007cites this paper
• EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil.

  2007cites this paper
• Running head: PAIN AND DISCOMFORT IN THE MYASTHENIA GRAVIS

  2007cites this paper
• Multiple sclerosis preceding CNS lymphoma: a case report.

  2007cites this paper
• Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.

  2007cites this paper
• Mycophenolate Mofetil: An Overview

  2006cites this paper
• Primary lymphoma of CNS, mycophenolate mofetil and lupus

  2006cites this paper
• What's in the Literature?

  2005cites this paper
• Treatment strategies in amyotrophic lateral sclerosis and its mimics

  2003cites this paper
• British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

  year unknowncites this paper
• Dermatitis : Systemic mmunosuppressive Therapy

  year unknowncites this paper